Relmada Therapeutics Inc (RLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 17,184 | 12,757 | 9,974 | 4,564 | 3,707 |
| Operating Income | -17,184 | -12,757 | -9,974 | -4,564 | -3,707 |
| Other Income | 281 | 1,639 | -699 | 37 | 38 |
| Pre-tax Income | -16,903 | -11,118 | -10,673 | -4,527 | -3,670 |
| Net Income Continuous | -16,903 | -11,118 | -10,673 | -4,527 | -3,670 |
| Net Income | $-16,903 | $-11,118 | $-10,673 | $-4,527 | $-3,670 |
| EPS Basic Total Ops | -1.05 | -0.73 | -0.72 | -0.38 | -0.38 |
| EPS Basic Continuous Ops | -1.05 | -0.73 | -0.72 | -0.39 | -0.38 |
| EPS Diluted Total Ops | -1.05 | -0.73 | -0.72 | -0.38 | -0.38 |
| EPS Diluted Continuous Ops | -1.05 | -0.73 | -0.72 | -0.39 | -0.38 |
| EBITDA(a) | $-17,183 | $-12,756 | $-9,973 | $-4,563 | $-3,706 |